
    
      The primary objective of this study is to evaluate the safety and effectiveness of 2
      concentrations of A-101 compared to Vehicle for the treatment of 4 seborrheic keratosis (SK)
      Target Lesions on the trunk, extremities and face.

      The secondary objectives of this study include duration of response of A-101. During the
      study, the investigator will identify 4 eligible SK Target Lesions on each subject on the
      trunk, extremities and face. For each subject, at least 1 SK Target Lesion must be on the
      face and at least 1 Target Lesion must be on the trunk or extremities. The Target Lesions
      will be treated at a maximum of two treatment visits.
    
  